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Streptococcus pneumoniae is a diverse species causing invasive as well as localized infections that result in massive global mor-
bidity andmortality. Strains vary markedly in pathogenic potential, but the molecular basis is obscured by the diversity and
plasticity of the pneumococcal genome. We have previously reported that S. pneumoniae serotype 3 isolates belonging to the
same multilocus sequence type (MLST) differed markedly in in vitro and in vivo phenotypes, in accordance with the clinical site
of isolation, suggesting stable niche adaptation within a clonal lineage. In the present study, we have extended our analysis to
serotype 14 clinical isolates from cases of sepsis or otitis media that belong to the sameMLST (ST15). In a murine intranasal
challenge model, five ST15 isolates (three from blood and two from ears) colonized the nasopharynx to similar extents. However,
blood and ear isolates exhibited significant differences in bacterial loads in other host niches (lungs, ear, and brain) at both 24
and 72 h postchallenge. In spite of these differences, blood and ear isolates were present in the lungs at similar levels at 6 h post-
challenge, suggesting that early immune responses may underpin the distinct virulence phenotypes. Transcriptional analysis of
lung tissue frommice infected for 6 h with blood isolates versus ear isolates revealed 8 differentially expressed genes. Two of
these were exclusively expressed in response to infection with the ear isolate. These results suggest a link between the differential
capacities to elicit early innate immune responses and the distinct virulence phenotypes of clonally related S. pneumoniae
strains.
Streptococcus pneumoniae (pneumococcus) is one of the fore-most bacterial pathogens in terms of global morbidity and
mortality. Its disease spectrum includes life-threatening infections
such as pneumonia, meningitis, and bacteremia as well as less-
serious but highly prevalent infections, including otitis media
(OM) and sinusitis. Young children and the elderly are at highest
risk, with global estimates of pneumococcal deaths in children
under 5 years of age approaching 1 million per year (1). Despite
this mortality, S. pneumoniae is a component of the normal mi-
croflora of the human nasopharynx. It is estimated that at any
given time, approximately 10 to 15% of adults and 25 to 40% of
healthy childrenmay be asymptomatically colonizedwith S. pneu-
moniae (2). Although only a small fraction of carriers progress to
invasive or localized pneumococcal disease, the scale of the de-
nominator results in massive global disease burden.
S. pneumoniae is a diverse, genetically plastic species, and the
93 known capsular serotypes are superimposed on 5,000 se-
quence types (ST) recognizable by multilocus sequence type
(MLST) analysis (3). It has a core genome of roughly 1,500 genes
common to all strains, with the remaining 30% of the genome
comprising accessory regions (AR) present in some but not all
clonal lineages. Individual S. pneumoniae strains differ markedly
in their capacity to cause either invasive or localized infections,
and both serotype and genetic background influence virulence
profile 4, 5). However, the vast heterogeneity has frustrated at-
tempts to identify any association between a given clonal lineage
or serotype and the propensity to cause invasive rather than local-
ized infections. Indeed, large molecular epidemiological studies
have not yielded consistent findings (6, 7).
We recently identified a link between human tissue tropism, as
judged by the source of a clinical isolate (blood versus ear), and
virulence profile in a mouse model by comparing multiple ST-
matched pairs of S. pneumoniae serotype 3 strains. In the murine
intranasal challenge model, only blood isolates caused sepsis,
while only otitis media isolates spread to the ear. These findings
were indicative of stable niche adaptation within a clonal lineage
(8). To further examine the nexus between the clinical source of
isolates and their respective virulence-related phenotypes, we
have now conducted similar studies in S. pneumoniae serotype 14
strains. Type 14 is a representative serotype conferring high inva-
sive disease potential (9–11). It is also one of the most common
etiologic agents of pneumonia in Latin America, the United King-
dom, and Spain and of otitis media in children under 5 years old
(12–14). To further understand the basis for the distinct virulence
profiles, we have also examined the nature of host innate immune
responses elicited by these clinical isolates during the early stages
of infection.
MATERIALS AND METHODS
Bacterial strains and growth conditions. S. pneumoniae strains used in
this study are listed in Table 1. Cells were grown in a casein-based, semi-
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synthetic liquid medium (CY) or in serum broth (SB), as required (8),
or onColumbia agar supplementedwith 5% (vol/vol) horse blood (BA) at
37°C in a CO2-enriched atmosphere. Bacterial stocks were prepared from
mid-log-phase cultures and stored at80°C in 20% glycerol.
MLST. For MLST analysis, the aroE, gdh, gki, recP, xpt, and ddl genes
were PCR amplified and sequenced as described by Spratt (15). The se-
quence types (ST) of the strains were determined from theMLSTdatabase
(http://www.pubmlst.org) based on the resulting allelic profiles.
ELISA for CPS quantitation. Total capsular polysaccharide (CPS)
produced by strains was quantified by enzyme-linked immunosorbent
assay (ELISA) using a modification of the method described previously
(16). Briefly, serial 2-fold dilutions of either purified type 14CPS standard
(American Type Culture Collection, USA) at a starting concentration of
10 g/ml or total CPS preparations of the strains included in this study
were coated on poly-L-lysine-treated NuncMaxiSorp flat-bottom 96-well
plates overnight at 4°C. After blocking with 1% fetal calf serum was per-
formed, the samples were reacted with a 1:10,000 dilution of group 14
typing sera (Statens Seruminstitut, Copenhagen, Denmark) for 2 h. The
plates were washed five times in wash buffer (0.05% Tween 20–phos-
phate-buffered saline [PBS]) and then reacted with a 1:20,000 dilution of
goat anti-rabbit IgG alkaline phosphatase conjugate (Sigma-Aldrich)
overnight at 4°C. After extensive washing, the plates were developed using
alkaline phosphatase substrate (Sigma) in diethanolamine buffer, and the
absorbance at 405 nm was read in a Spectramax M2 spectrometer (Mo-
lecular Devices, CA, USA).
Animal studies.Animal experiments were approved by theUniversity
of Adelaide Animal Ethics Committee. For each test strain, two groups of
five outbred 6-week-old female Swiss mice were anesthetized by intraper-
itoneal injection of pentobarbital sodium (Nembutal; Rhone-Merieux) at
a dose of 66 g per g of body weight. They were then intranasally chal-
lenged with 30 l of bacterial suspension containing approximately 1 
108 CFU in SB. The challenge dose was confirmed retrospectively by serial
dilution and plating on BA. Groups of five mice were euthanized by CO2
asphyxiation at either 24 or 72 h. Blood and tissue samples (lungs, naso-
pharynx, brain, and ear) were harvested and pneumococci enumerated in
blood or tissue homogenates as described previously (8, 16). For in vivo
competition experiments, groups of mice were challenged intranasally
with a mixed inoculum comprising approximately 5  107 CFU of each
strain, as previously described (17). The competitive index (CI) within
nasopharyngeal, ear, lung, and brain samples was determined at 24 h and
72 h postchallenge by plating on selective and nonselective media and
calculating the ratio of ear isolates to blood isolates relative to the input
ratio. For the purposes of CI calculation, when a given strain was not
detected in a particular niche, it was assigned a CFU value equivalent to
50% of the detection threshold.
Detroit 562 adherence and invasion assays.Detroit 562 (human na-
sopharyngeal carcinoma) cells were grown in a 1:1 mix of Dulbecco’s
modified Eagle medium (Gibco) and Ham’s F-12 nutrient mixture
(Gibco) supplementedwith 5% fetal bovine serum, 2mML-glutamine, 50
IU of penicillin, and 50 g/ml streptomycin. Confluent monolayers in
24-well plates were washed with PBS and infected with pneumococci (ap-
proximately 5 105 CFUperwell) in a 1:1mixture of the culturemedium
described above (without antibiotics) and CY (pH 7.4). Plates were
centrifuged at 500 g for 5min and then incubated at 37°C in 5%CO2 for
2.5 h.Monolayers werewashed 3 times in PBS, and adherent bacteria were
released by treatment with 100 l trypsin–EDTA followed by 400 l
0.025% Triton X-100. Lysates were serially diluted and plated on BA to
enumerate adherent bacteria. Invasion assays were carried out essentially
as described above, except that after the postadherence washing step, cul-
tures were incubated for 1 h in fresh medium supplemented with 200 g
gentamicin and 10g benzylpenicillin perml to kill extracellular bacteria,
after which monolayers were again washed, lysed, serially diluted, and
plated on BA, as described above.
PCR arrays. At 6 h postinfection, lung and nasopharyngeal tissue was
harvested from infected or sham-infected mice and homogenized. RNA
was extracted using a PureLink RNAminikit (Life Technologies), includ-
ing on-columnDNase digestion, according to themanufacturer’s instruc-
tions. cDNA synthesis was carried out using a RT2 First Strand kit (Qia-
gen). RNA was analyzed on a LightCycler 480 II system (Roche) by
quantitative reverse transcriptase PCR (qRT-PCR) using a RT2 Profiler
PCR array mouse innate and adaptive immune responses kit (Qiagen),
according to the manufacturer’s instructions (18). Data were analyzed
using PCR Array data analysis software provided by the manufacturer.
Fluorescence-activated cell sorter (FACS) detection of Ly-6G- and
F4/80-positive cells in blood and BAL fluid. Blood was collected from
infected and uninfected mice into heparin tubes by cardiac puncture.
Blood leukocytes were extracted by lysing the red blood cells (RBC) with a
hypotonic shock. Bronchoalveolar lavage (BAL) was performed using 1
ml of ice-cold PBS.
The blood leukocytes or BAL fluid cells were washed in ice-cold PBS
and fixed in 1% paraformaldehyde–PBS over night at 4°C. Before immu-
nofluorescence labeling, the leukocytes were washed with PBS and per-
meabilized with 0.1 ml of 0.1% Triton X100–PBS for 30 s. The cells were
thenwashed againwith PBS andwere then incubatedwithmonoclonal rat
anti-mouse Ly-6G (BD Biosciences; 551459) or monoclonal rat anti-
mouse F4/80 (SantaCruz Biotechnology; SC-52664) at room temperature
for 1 h. Ly-6G (neutrophil marker) or F4/80 (monocyte/macrophage
marker) was detected by incubation with Alexa 488-conjugated donkey
anti-rat Ig (Invitrogen; A21208) at room temperature for 1 h. Fluores-
cence data were acquired by the use of a BD FACSCanto system (serial no.
V0130) or a BD LSR II system with a high-throughput sampler (serial no.
H1169) plus BD FACSDiva software (version 5.0.3) and were analyzed
with WEASLE v2.6 software. The fluorescence intensity of Alexa 488 was
proportional to the expression level of Ly-6G or F4/80. The data are re-
ported as the product of geometricmean (GM) fluorescence intensity and
the total number of Ly-6G- or F4/80-positive cells. The data are presented
as means and standard errors (SE), and differences were analyzed using
Student’s t test.
Examination of lung tissue with HE staining or immunofluores-
cence labeling. After the blood and BAL fluid were collected, the lungs of
infected and uninfected mice were removed and fixed in 4% formalde-
hyde overnight at 4°C, embedded in paraffin, sectioned, stained with he-
matoxylin-eosin (HE), and examined by light microscopy. Alternatively,
sections were labeled with rat anti-mouse Ly-6G or F4/80 followed by
Alexa-488-conjugated anti-rat IgG and examined by fluorescencemicros-
copy (AX 70; Olympus).
RESULTS
Initial characterization of serotype 14 clinical isolates. The pur-
pose of this study was to compare pneumococci belonging to the
same serotype and clonal lineage derived from distinct host
niches. Therefore, we carried outMLST analysis on 18 serotype 14
strains, comprising 9 blood and 9 ear isolates. The two predomi-
nant STs were ST15 (n  5) and ST130 (n  5). Of the other
strains, two belonged to ST124 and ST129, while the others were
all assigned to new STs by http://pubmlst.org but were not further
investigated. We focused on ST15 because three isolates origi-
TABLE 1 S. pneumoniae serotype 14 isolates used in this study
Straina MLST Source
ST15/9-47 ST15 Ear
ST15/51742 ST15 Ear
ST15/4495 ST15 Blood
ST15/4534 ST15 Blood
ST15/4559 ST15 Blood
a Strains were isolated between 1988 and 1996 from patients at either the Women’s and
Children’s Hospital, North Adelaide, South Australia, or the Alice Springs Hospital,
Northern Territory, Australia. The MLST of each strain was determined as described in
Materials and Methods.
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nated from blood and two from ears (Table 1). All ST15 strains
were in the opaque phase, as judged by the opacity phenotype seen
during growth on Todd-Hewitt broth supplemented with yeast
extract (THY)–catalase plates (16), and the total capsular polysac-
charide production levels were similar for all strains, as judged by
ELISA (data not shown).
Virulence phenotype of ST15 blood and ear isolates.The vir-
ulence profiles of the various ST15 strains were then examined in
amurine intranasal challengemodel. Group sizes were 16 each for
one blood (ST15/4495) and one ear isolate (ST15/9-47) (both se-
lected at random) andn 5 for the remaining strains.Numbers of
the respective strains in various host niches (nasopharynx, lungs,
blood, brain, and ear) were quantitated at 24 h and 72 h postchal-
lenge (Fig. 1). None of the strainswere detected in the blood of any
of the mice at either time point (data not presented). The three
blood isolates (ST15/4495, ST15/4534, and ST15/4559) and the
two ear isolates (ST15/9-47 and ST15/51742) all exhibited similar
capacities to colonize the nasopharynx at both 24 h and 72 h
postinfection, with theGMbacterial load in this niche in the range
of 104 to 105 CFU (Fig. 1A). There were no significant differences
in either infection rates or GM bacterial loads. However, signifi-
cant differences between blood and ear isolates were observed in
the other host niches. Neither of the ear isolate strains was detect-
able in the lungs of any of the infectedmice at either time point. In
contrast, the ST15/4495 blood isolate strain was present in the
lungs of 14/16 mice at 24 h and 8/16 at 72 h postchallenge (P 
0.0001 and P  0.0032, respectively; Fisher exact test). A similar
trend was seen for the other two blood isolates (ST15/4534 and
ST15/4559), with 50% of lungs colonized at 72 h (Fig. 1B). The
opposite tropism was observed in the brain. None of the three
ST15 blood isolates were detected in the brains of any of the mice
at either time point. However, the ST15/9-47 ear isolate was de-
tected in the brains of 15/16mice and 11/16mice at 24 h and 72 h,
respectively (P  0.0001 in both cases). The other ear isolate
(ST15/51742) was present in the brains of 5/5 and 3/5mice at 24 h
and 72 h, respectively (P 0.01 relative to any of the blood isolates
at 24 h) (Fig. 1C). In the infectedmice, bacterial loads in the brain
were in the range of 103 to 105 CFU. All five ST15 isolates were able
to spread to the ear compartment after intranasal challenge, but
the proportion of mice whose ears were infected with the ST15/
9-47 ear isolate was significantly greater than that of mice chal-
lenged with the ST15/4495 blood isolate (16/16 versus 7/16 and
15/16 versus 8/16 at 24 h and 72 h, respectively; P  0.0008 and
P 0.0155, respectively) (Fig. 1D). The GM bacterial load in the
ears for ST15/9-47 was also significantly greater than that for
ST15/4495 at both 24 h and 72 h (P  0.0015 and P  0.0020,
respectively). Similar trends were also seen in the mice challenged
with the other ST15 ear isolate and the two other blood isolates.
Collectively, these results show that pneumococci of the same se-
rotype and ST exhibit distinct in vivo phenotypes in accordance
with the clinical site of isolation.
In vivo competition between ST15/4495 and ST15/9-47. The
distinct in vivo tropism observed for the ST15 ear and blood iso-
lates could be attributable to differences in expression of bacterial
virulence factors on the bacterial surface or released into the en-
vironment and/or to differences in the nature of the host innate
immune responses elicited by the respective strains. Thus, the
presence of a strain with superior virulence characteristics in a
given niche may enhance the virulence of a “passenger” strain. To
explore this, we conducted in vivo competition experiments in
which two groups of mice were challenged with equal numbers of
ST15/4496 and ST15/9-47, and the relative numbers of each strain
were determined in various host niches at 24 h and 72 h postchal-
lenge. In order to distinguish the strains, it was necessary to con-
struct erythromycin-resistant derivatives of each strain by trans-
formation with plasmid pAL3 (19). Introduction of the plasmid
had no effect on the bacterial growth rate of either strain (data not
shown).
Two competition experiments were performedwith 5mice per
group for each time point. In one experiment, mice were chal-
lenged with equal numbers of ST15/4496 and ST15/9-47:pAL3; in
the other experiment, mice were challenged with equal numbers
of ST15/4496:pAL3 and ST15/9-47. Tissue samples were plated on
BA or BA plus erythromycin to enable calculation of the ratio of
sensitive organisms to resistant organisms and hence of the com-
petitive index (CI). Data pooled from the two experiments are
shown in Fig. 2. In spite of the similar capacities of ST15/4495 and
ST15/9-47 to colonize the murine nasopharynx when challenged
in isolation (Fig. 1A), the ear isolate had a significant competitive
advantage over the blood isolate in the mixed-infection model in
the nasopharynx at 24 h (P 0.001) and at 72 h (P 0.0001), by
which time themedian CI was approximately 105 (Fig. 2). The ear
isolate also predominated in both the ear and brain compartments
at both time points (P 0.0001 for brain at 24 h and 72 h and for
ear at 24 h; P  0.05 for ear at 72 h). Moreover, whereas small
numbers of the blood isolate were present along with the domi-
nant ear isolate in the ears of all the infectedmice, the blood isolate
was never detected in brain tissue of any of the mice at either time
point. These findings are understandable, given that access to both
the brain and the ear compartments occurs via the nasopharynx,
where the ear isolate was present at a 105-fold excess over the
blood isolate. A distinct scenario occurred in the lungs. Only 6/10
mice had detectable pneumococci in the lungs at either time point,
and in these mice, neither strain had a significant competitive
advantage overall (Fig. 2). This was the case in spite of the fact that,
when used in isolation for the challenge, only the blood isolate was
able to persist in the lungs at either 24 h or 72 h (Fig. 1B). In the
competition experiment, the ear isolate outcompeted the blood
isolate in 4/6 infected mice, whereas the blood isolate outcom-
peted the ear isolate in 2/6 mice (Fig. 2). The intranasal challenge
inoculum was instilled into the nares under general anesthesia,
and a proportion of the dose was aspirated directly into the lungs
during the challenge (approximately 106 CFU).When instilled on
their own, ST15/9-47 organisms entering the lung during chal-
lenge were cleared within 24 h, whereas when ST15/4495 organ-
ismswere instilled on their own, the blood isolate was able to resist
innate defenses and persist in the lung. However, in the coinfec-
tion model, significant numbers of the ear isolate were present in
a proportion of the mice at both 24 h and 72 h. These findings
indicate that the presence of the ST15/4495 blood isolate, at least
during the immediate postchallenge period, is necessary for per-
sistence of the ST15/9-47 ear isolate in the lung compartment.
In vitro adherence and invasion. To further explore the basis
for the enhanced nasopharyngeal colonization fitness of ST15/9-
47, the adherence phenotype of all the ST15 isolates was assessed
in vitro usingDetroit 562 (human nasopharyngeal) cells (Table 2).
There were significant differences between several of the strains in
total in vitro adherence. Two of the blood isolates (ST15/4495 and
ST15/4534) were significantly less adherent than the ST15/9-47
ear isolate (P  0.01 and P  0.001, respectively). The other ear
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FIG 1 Comparative virulence of ST15 blood and ear isolates. Groups of mice were challenged intranasally with the three blood isolates (ST15/4495, ST15/4534, and
ST15/4559) and the two ear isolates (ST15/9-47 and ST15/51742), and numbers of pneumococci in the nasopharynx, lungs, brain, and ear at either 24 h or 72 h
postchallenge were determined. For ST15/4495 and ST15/9-47, 16 challengedmice were examined at each time point compared with 5mice at each time point for the
remaining strains. Blood isolates are represented by open gray symbols; ear isolates are represented by filled black symbols. The horizontal bars denote themedianCFU
for each group; the dotted horizontal lines indicate the lower limit of detection, and symbols on the lines denote that no bacteria were detected. Differences in infection
rates (number of infected versus number of uninfectedmice) were analyzed using the Fisher exact test. **, P 0.01; ****, P 0.0001.
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isolate (ST15/51742) was even more adherent than ST15/9-47
(P  0.05). The adherence of the third blood isolate (ST15/
4559) was not significantly different from that of ST15/9-47,
but that isolate was significantly less adherent than the second
ear isolate, ST15/51742 (P  0.01). The capacity of the ST15/
9-47 ear isolate and the ST15/4495 blood isolate to invade De-
troit cells was also investigated (Table 2), but no significant
difference was observed.
Transcriptional analysis of host innate responses. Although
only the blood isolates are detectable in the lungs at 24 h, ear
isolates are delivered into the lungs during challenge but are
cleared by host innate defenses by 24 h. In a pilot experiment, we
found similar bacterial loads in the lungs of mice challenged with
either ST15/4495 or ST15/9-47 at 6 h postchallenge (107 to 108
CFU in both cases; result not shown). We therefore investigated
whether differences in host responses during the immediate post-
challenge period might have influenced bacterial clearance from
the lungs. Mice were challenged with either the blood isolate
(ST15/4495) or the ear isolate (ST15/9-47) or were sham infected
(anesthetized and inoculated with 30 l SB). Total RNA was iso-
lated from lungs and nasopharyngeal tissue 6 h after challenge.
Expression of 84 key immune response geneswas then quantitated
using RT-PCR arrays. Compared to levels in sham-infected sam-
ples, a total of 35 genes were induced in the lungs, as judged by a
significant increase in the mRNA level following challenge with at
least one of the two ST15 strains (Table 3). Overall, the pattern of
gene expression indicated a generally proinflammatory response
in the lungs at 6 h postchallenge; genes encoding a number of
proinflammatory cytokines, including interleukin-1	 (IL-1	),
IL-1
, IL-23a, IL-6, and tumor necrosis factor alpha (TNF-	),
were upregulated. Other genes involved in regulating the immune
response were also increased in expression. These included genes
encoding the chemokines CCL12, a murine homolog of (human)
CCL2, and CXCL10, which is known to be induced by gamma
interferon (IFN-), a proinflammatory cytokine that also showed
increased expression following pneumococcal challenge. Expres-
sion of the CCR5 chemokine receptor was also elevated at the
mRNA level. Genes encoding elements involved in pathogen rec-
ognition and signaling during immune responses, such asMyd88,
Toll-like receptor 3 (TLR3), TLR6, TLR7, Nod2, Ddx58, JAK2,
and NF-BI	, were differentially expressed in challenged samples
compared to sham-infected samples. Other upregulated genes in-
cluded those encoding the CD11b integrin (ITGAM) and the as-
sociated adhesion molecule ICAM1, inflammasome component
NLRP3, and granulocyte-macrophage colony-stimulating factor
(GM-CSF) CSF2.
Some strain-strain differences were observed, with 8 genes
showing significant differential levels of expression in lungs fol-
lowing challenge with ST15/4495 compared to challenge with
ST15/9-47 (Table 4). Of these, 6 genes were upregulated by both
challenge strains compared to resting samples but to a signifi-
cantly greater degree following challenge with ST15/4495. These
included those encoding the proinflammatory cytokines TNF-	
and IL-6, the type I interferon IFN-
, the costimulatory molecule
CD40, the transcription factor Tbet (TBX21), and the chemokine
CCL12. The remaining 2 genes, encoding APCS and IL-2, were
found to be upregulated only following challenge with ST15/9-47.
FIG 2 In vivo competition between ST15/9-47 (ear isolate) and ST15/4495
(blood isolate). Data shown are pooled from two competition experiments
performed with 5 mice per group for each time point (24 h and 72 h postchal-
lenge). In one experiment, mice were challenged with equal numbers (5 107
CFU each) of ST15/4495 and ST15/9-47:pAL3 (open symbols); in the other
experiment, mice were challenged with equal numbers of ST15/4495:pAL3
and ST15/9-47 (solid symbols). The competitive index (CI) is shown as log10
CI for each tissue of each mouse. The horizontal dotted lines denote the geo-
metric mean CI for each tissue. Statistical differences between the log-trans-
formed geometric mean CI and a hypothetical value of 0 (ratio of 1:1) in each
niche were analyzed using the two-tailed Student’s t test. ns, not significant; *,
P 0.05; ***, P 0.001; ****, P 0.0001.
TABLE 2 Adherence to and invasion of Detroit 562 cells
Strain Source Adherencea (CFU/well SEM) Invasion (CFU/well SEM)
ST15/9-47 Ear 7.88 105 0.78 105 3.50 105 0.65 103
ST15/51742 Ear 1.19 105 0.10 106* Not tested
ST15/4495 Blood 3.75 105 0.56 105** 3.95 105 0.28 103
ST15/4534 Blood 2.85 105 0.27 105*** Not tested
ST15/4559 Blood 7.50 105 0.59 105 Not tested
a Significant differences in adherence relative to that of ST15/9-47 are indicated as follows: *, P 0.05; **, P 0.01; ***, P 0.001 (Student’s t test, two-tailed).
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Since the nasopharynx is the first host environment to which
the bacteria are exposed during infection, we examined whether
the blood isolate (ST15/4495) and the ear isolate (ST15/9-47) also
elicited differential levels of induction of innate immune response
genes in this niche at 6 h postinfection. However, we found no
significant differences between sham-infected mice and those
challenged with either strain in expression of any of the 84 genes
analyzed (data not shown).
Cellular and histopathological responses to lung infection.
We also examined blood, BAL fluid, and lung tissue for cellular
recruitment and histopathological changes. At 6 h postinfection,
there were very few cells in the BAL fluid and there were no sig-
nificant differences between sham-infected mice and those in-
fected with either ST15/9-47 or ST15/4495 in the numbers of BAL
fluid neutrophils (Ly-6G-positive cells) or monocyte/macro-
phages (F4/80-positive cells), as determined by flow cytometry
(result not shown). However, a similar FACS analysis of blood
leukocytes showed numbers of neutrophils (Fig. 3A), but not
monocyte/macrophages (Fig. 3B), in ST15/4495-infected mice
that were significantly higher than those seen with either sham-
infected or ST15/9-47-infected mice at 6 h (P  0.05 in both
cases). A similar increase in the blood neutrophil count in ST15/
4495-infectedmice relative to either sham-infected or ST15/9-47-
infected mice at 6 h was also evident from differential cell counts
of blood films (P 0.05 and P 0.01, respectively) (Fig. 3C).
Examination of HE-stained lung sections at 6 h revealed early
signs of tissue damage, including congested capillaries, thickened
alveolar walls, swollen cuboidal epithelial cells of the bronchioles,
and the presence of secretions in the alveolar and bronchiolar
spaces, most notably in ST15/4495-infected mice (Fig. 4A). These
features were used to develop an 8-point system for scoring histo-
pathological changes (Fig. 4B). The mean aggregate score ( SE)
for ST15/4495-infected mice (2.8 1.3) was higher than that for
either the ST15/9-47-infected mice (1.4  0.57) or the sham-in-
fected mice (0.5  0.33), but this trend did not reach statistical
significance.
Finally, we examined lung sections for cellular infiltration by
immunofluorescence microscopy after staining with anti-Ly-6G
(Fig. 5) or anti-F4/80 (not shown). This revealed patchy neutro-
phil infiltration in 2/5 mice infected with the ST15/4495 blood
isolate and 1/5 mice infected with the ST15/9-47 ear isolate, com-
pared with 0/5 for the control mice. No differences between
groups in staining for the monocyte/macrophage marker were
seen.
TABLE 3 Genes significantly upregulated in infected relative to sham-
infected lung tissuea
Gene
product
ST15/4495 infected vs sham
infected
ST15/9-47 infected vs sham
infected
Fold gene
expression
change Significance
Fold gene
expression
change Significance
APCS 5.15 **
C5ar1 14 * 8.47 **
CCL12 36.61 * 15.56 **
CCR5 10.68 * 5.97 **
CD14 61.12 **
CD40 6.21 * 2.55 *
CD86 3.51 * 2.51 **
CSF2 19.34 *
CXCL10 310.55 **
Ddx58 2.36 *
ICAM1 7.91 * 5.13 *
IFN-	2 2.50 *
IFN-
1 96.15 ***
IFN- 17.2 ** 12.25 ***
IL-10 17.09 *
IL-1 29.81 ** 16.64 ***
IL-1
 88.28 * 52.60 **
IL-1r1 2.1 *
IL-2 4.95 **
IL-23	 40.9 **
IL-6 312.35 **
IRF7 4.01 * 3.80 *
ITGAM 3.73 **
JAK2 3.29 ** 4.41 *
Mx1 152.64 *
Myd88 12.3 * 5.22 *
NF-BI	 20.34 *
NLRP3 36.61 ***
Nod2 9 **
SLC111 4.26 * 5.25 *
TBX21 2.4 **
TLR3 4.8 **
TLR6 3.84 **
TLR7 4.80 **
TNF 119.21 ** 50.78 *
IL-1r1 2.1 *
a Data for genes upregulated significantly after infection with both ear and blood
isolates are highlighted in bold type. Statistical significance is indicated as follows: *,
P 0.05; **, P 0.01; ***, P 0.001 (Student’s t-test, two-tailed).
TABLE 4 Genes differentially induced by infection with ST15/9-47 versus ST15/4495a
Gene product
ST15/4495 vs sham infected ST15/9-47 vs sham infected ST15/9-47 vs ST15/4495
Fold gene
expression change Significance
Fold gene
expression change Significance
Fold gene
expression change Significance
APCS 1.10 ns 5.15 ** 5.67 **
IL-2 1.09 ns 4.95 ** 5.40 *
CCL12 36.61 * 15.56 ** 2.35 *
CD40 6.21 * 2.55 * 2.43 *
IFN-
1 96.15 *** 17.84 ns 5.39 ***
IL-6 1,842.35 P 0.06 312.35 ** 5.90 *
TNF 119.21 ** 50.78 * 2.35 *
TBX21 2.4 ** 1.02 ns 2.36 ****
a Statistical significance is indicated as follows: ns, not significant; *, P 0.05; **, P 0.01; ***, P 0.001; ****, P 0.0001 (Student’s t-test, two-tailed).
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DISCUSSION
S. pneumoniae is a genetically diverse pathogen, and individual
isolates vary markedly in their capacity to progress from asymp-
tomatic nasopharyngeal carriage to causing either localized or sys-
temic disease. The plethora of capsular serotypes and clonal lin-
eages (MLST types) no doubt contribute to their adaptability in
different hostmicroenvironments, but they have also complicated
previous attempts to unequivocally associate particular serotypes
or clonal groups with specific virulence attributes (6, 7). However,
we have previously described multiple examples of serotype 3
strains belonging to the same ST that consistently and reproduc-
ibly exhibit distinct virulence phenotypes in mice that directly
correlate with the original site of isolation from human patients
(i.e., ear versus blood) (8). This suggested that, at least in serotype
3, pneumococci exhibit stable niche adaptation within a clonal
lineage.
In the present study, we investigated blood and ear isolates
belonging to serotype 14, a common cause of OM as well as of
invasive disease worldwide (11). This serotype also exhibits high
rates of antimicrobial resistance (20). ST15 was one of the domi-
nant STs in our collection and was represented among clinical
isolates from cases of sepsis and OM. ST15 blood and ear isolates
were able to colonize the murine nasopharynx to roughly similar
extents. However, the blood isolate (ST15/4495) was significantly
better at colonization and persistence in the lung, while the ear
isolate (ST15/9-47) was significantly better able to penetrate and
persist in the brain and ears. Similar preferential tropism results
for the brain and ear were observed for the other ST15 ear isolate
(ST15/51742), while the two other ST15 blood isolates (ST15/
4534 and ST15/4559) colonized the lungs in a proportion of in-
fected mice. Significantly, neither of the ear isolates was detected
in the lungs of any of the mice at either 24 or 72 h, while none of
the three blood isolates were ever detected in the brain. Further-
more, none of the ST15 blood or ear isolates were detected in the
blood at any time during the experiment. This is consistent with
the long-known fact that mice exhibit a high degree of innate
resistance to sepsis after challenge with serotype 14 S. pneumoniae
strains.However, these findings also suggest that the very high rate
of meningitis that occurs after intranasal challenge with either of
the ST15 ear isolates was not a consequence of hematogenous
spread. Likely alternative routes for pneumococci from the naso-
pharynx to the brain include direct invasion by retrograde axonal
transport along olfactory neurons into the central nervous system
(CNS) (21). Collectively, the findings reported above provide ro-
bust evidence for the existence of distinct pathogenic profiles for
serotype 14 S. pneumoniae strains belonging to the same ST (in
this case, ST15). In a previous study (22), modest differences in
bacterial loads in the blood of mice 6 h after intraperitoneal chal-
lenge with three serotype 14 blood isolates belonging to ST124
were detected, although the bacteremia was transient and subclin-
ical. However, in the present study, we not only observed highly
significant differences in virulence and pathogenic profiles be-
tween isolates belonging to the same serotype and clonal lineage
but also found a close correlation between pathogenic profiles in
mice and the original sites of isolation from human cases of pneu-
mococcal disease. This extends an observation that we have pre-
viously reported for serotype 3 strains belonging to ST180, ST232,
and ST233 (8). Thus, stable niche adaptation within a clonal lin-
eage appears to be a general phenomenon.
Notwithstanding the conclusions presented above, the in vivo
competition experiments in the present study yielded some unex-
pected findings. First, although the ear and blood isolates were
able to colonize the nasopharynx to similar levels when adminis-
tered individually, the ST15/9-47 ear isolate massively outcom-
peted the ST15/4495 blood isolate in this niche in the coinfection
model. The reason for this is not clear. Neither strain predomi-
nated when the two were cocultured in vitro, and the two strains
express the same bacteriocin genes (data not presented). Never-
theless, this finding accounts for the dominance of ST15/9-47 in
the brain and ear in the coinfectionmodel, since these host niches
are presumably accessed via the nasopharynx, where the ear iso-
late already enjoyed a 105-fold numeric advantage. On the other
hand, the data from the individual challenge experiments might
lead one to predict that the ST15/4495 blood isolate would enjoy a
FIG 3 Peripheral blood leukocyte counts. (A and B) Leukocytes isolated from
peripheral blood collected at 6 h from control (sham-infected) mice or from
those infected with the blood isolate (ST15/4495) or the ear isolate (ST15/9-
47) were examined by FACS analysis after staining with anti-Ly-6G (A) or
anti-F4/80 (B), as described in Materials and Methods. Data are presented as
the product of geometric mean fluorescence intensity and the total number of
positive cells (GMFIn) for the respective marker ( SE). (C) Alternatively,
blood films were subjected to differential cell counts, and neutrophil numbers
are expressed as a percentage of total leukocyte levels (mean SE). Statistical
significance is indicated as follows: *, P 0.05; **, P 0.01 (Student’s paired,
two-tailed t test).
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competitive advantage in the lungs, but this was not the case, with
neither strain predominating. Similar numbers of ear and blood
isolates were delivered into the lungs during challenge under gen-
eral anesthesia, and bacterial loads in lung tissue at 6 h postchal-
lenge were similar. However, in the individual challenge studies,
ST15/9-47 was completely cleared from the lungs of all mice by 24
h, while ST15/4495 was able to persist. There are two possible
explanations for this. ST15/4495 may secrete a (yet to be identi-
fied) virulence factor that can act in trans and support survival of
ST15/9-47 in the mixed-infection model. Alternatively, differ-
ences in host innate immune responses elicited by the blood and
ear isolates could account for the distinct pathogenic profiles.
Clearly, responses triggered by ST15/4495 enable this strain to
persist in the lung environment. However, this may create a host
microenvironment that also enables persistence of coadminis-
tered strains such as ST15/9-47 which would otherwise have been
cleared.
To establish if the host immune response could play a role in
the distinct pathogenic profiles of the ST15 blood or ear isolates,
we examined the transcriptional responses of 84 genes represent-
ing the major pathways involved in the innate and adaptive im-
mune response to microbial pathogens. Unsurprisingly, infection
FIG 4 Lung histopathology. HE-stained lung sections from control (sham-infected) mice or from those infected with the blood isolate (ST15/4495) or the ear
isolate (ST15/9-47) at 6 h were examined by light microscopy. (A) Representative sections from each group are shown. Bar, 0.1 mm. Slides were also scored
(blind) according the following 8-point scheme: congested capillaries (fine arrows) were scored 0 to 2; thickened alveolar wall (arrowheads) were scored 0 to 2;
swollen cuboidal epithelial cells of the bronchioles (thick arrows) were scored 0 to 2; and secretions in the alveolar and bronchiole space (open arrows) were
scored 0 to 2. (B) Data were examined with Student’s unpaired two-tailed t test and are presented as mean SE for each group.
FIG 5 Neutrophil infiltration. Lung tissue from infected or control mice was fixed, sectioned, and labeled with rat anti-mouse Ly-6G or F4/80, followed by
Alexa-488-conjugated anti-rat IgG and examined by fluorescence microscopy. Bar, 50 m.
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with either strain induced a variety of proinflammatory genes.
However, the strain-specific differences observed provide us with
important clues as to how the immune response may vary, yield-
ing very different patterns of infection from two clonally related
strains. Six of the eight genes that were differentially expressed in
response to infection with ST15/4495 relative to ST15/9-47 are
upregulated in response to both strains relative to sham-infected
lungs but are induced more strongly in response to ST15/4495.
This suggests that while both strains induce a broadly similar re-
sponse, one of the features distinguishing the two is the strength of
the responses induced at similar bacterial loads. Those responses
included increased expression of genes encoding CCL12, IL-6,
TNF-	, IL-1
, and CD40, which points to an overall stronger
macrophage response to the blood isolate than to the ear isolate
(23–29). BAL fluid collected at 6 h postinfection contained very
few cells, and there were no significant differences between sham-
infected mice and those infected with either of the isolates in this
regard. However, mice infected with the ST15/4495 blood isolate
exhibited significant neutropenia relative to sham-infected or
ST15/9-47-infected mice at this early time point. Results of a his-
topathological examination were also suggestive of increased lung
damage in mice infected with ST15/4495.
The findings presented above have parallels with those from a
previous study in which we compared host transcriptional re-
sponses to highly invasive and noninvasive S. pneumoniae strains
belonging to serotype 1 in a similar intranasal challenge model.
We showed that a total of 29 genes of the 84 on the array showed
significant upregulation; of those, 22 were also upregulated in the
present study. The two type 1 strainswere present in roughly equal
numbers in the lung at 6 h, but the invasive strain triggered amuch
stronger type I interferon response, which facilitated invasion of
the pleural cavity followed by the blood (18).
In the present study, we identified two genes (encoding APCS
and IL-2) that were significantly upregulated only in the mice
challenged with the ST15/9-47 ear isolate compared to the sham-
infected mice; infection with the blood isolate had a negligible
effect on their expression. Therefore, it is tempting to speculate
that expression of the genes encoding APCS and IL-2 might con-
tribute to the clearance of the ear isolate from the lungs. In partic-
ular, serum amyloid P, the protein encoded by the APCS gene, is
known to play a role in complement deposition on the pneumo-
coccus, improving phagocyte efficiency and aiding clearance of
the pathogen (30).
In this study, we have provided further evidence that S. pneu-
moniae strains belonging to the same serotype and ST can elicit dis-
tinct host innate immune responses and cause different types of dis-
ease. Future comparative genomic and transcriptomic analyses of
these ST-matched strain pairs with distinct virulence phenotypes
should enable identification of specific bacterial determinants of tis-
sue tropism. This knowledge may, in turn, provide opportunities to
develop improved vaccine formulations capable of eliciting protec-
tion against the full spectrum of pneumococcal disease.
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